• 1. Evolution of calcium phosphate precipitation in hanging drop vapor diffusion by in situRaman microspectroscopy
  Gloria Belén Ramírez-Rodríguez,José Manuel Delgado-López,Jaime Gómez-Morales CrystEngComm, 2013,15, 2206-2212
• 2. Evidence for the intrinsic nature of band-gap states electrochemically observed on atomically flat TiO2(110) surfaces?
  Shintaro Takata,Yoshihiro Miura Phys. Chem. Chem. Phys., 2014,16, 24784-24789
• 3. Emerging 2D hybrid nanomaterials: towards enhanced sensitive and selective conductometric gas sensors at room temperature
  Hanie Hashtroudi,Ian D. R. Mackinnon J. Mater. Chem. C, 2020,8, 13108-13126
• 4. Dissociation of aryl sulfonyl phthalimide radical anions: relevance to the biological activity of arylsulfonyl amides?
  Abdelaziz Houmam,Emad M. Hamed Chem. Commun., 2012,48, 11328-11330
• 5. Examination of deposit in commercial diluted phosphoric acid
  Analyst, 1880,5, 146-147

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Piperidines Piperidinecarboxylic acids
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Piperidines Piperidinecarboxylic acids and derivatives Piperidinecarboxylic acids

Professional Introduction to Tert-butyl (3R)-3-bromopiperidine-1-carboxylate (CAS No. 1354000-03-5)

Tert-butyl (3R)-3-bromopiperidine-1-carboxylate, with the chemical formula C₁₀H₁₄BBrN₂O₂, is a specialized organic compound that has garnered significant attention in the field of pharmaceutical research and development. This compound, identified by its CAS number CAS No. 1354000-03-5, serves as a crucial intermediate in the synthesis of various bioactive molecules, particularly those targeting neurological and metabolic disorders. Its unique structural features, including the presence of a brominated piperidine ring and a tert-butyl ester group, make it a versatile building block for medicinal chemists.

The significance of Tert-butyl (3R)-3-bromopiperidine-1-carboxylate lies in its ability to undergo various chemical transformations, which are essential for constructing complex drug molecules. The stereochemistry of the piperidine ring, specifically the (3R) configuration, plays a pivotal role in determining the biological activity of the resulting compounds. This stereochemical purity is often achieved through enantioselective synthesis methods, which highlight the compound's importance in fine chemical manufacturing.

In recent years, there has been a surge in research focused on developing novel treatments for neurological disorders such as Parkinson's disease and Alzheimer's disease. Piperidine derivatives have emerged as a promising class of compounds due to their ability to interact with central nervous system receptors. Among these derivatives, Tert-butyl (3R)-3-bromopiperidine-1-carboxylate has been explored for its potential to modulate dopaminergic and cholinergic pathways. Preliminary studies have indicated that derivatives of this compound exhibit promising pharmacological properties, making them attractive candidates for further development.

The bromine atom in the structure of Tert-butyl (3R)-3-bromopiperidine-1-carboxylate provides a reactive site for further functionalization, enabling the synthesis of more complex molecules. This reactivity has been exploited in various cross-coupling reactions, such as Suzuki-Miyaura and Buchwald-Hartwig couplings, which are fundamental in constructing biaryl and heterocyclic systems, respectively. These reactions are pivotal in drug discovery pipelines, allowing chemists to create structurally diverse libraries of compounds for high-throughput screening.

One of the most compelling aspects of Tert-butyl (3R)-3-bromopiperidine-1-carboxylate is its role in the development of enzyme inhibitors. Piperidine-based inhibitors have shown efficacy against various therapeutic targets, including kinases and proteases. The tert-butyl ester group can be hydrolyzed under physiological conditions to release a free carboxylic acid group, which can be further functionalized to enhance binding affinity and selectivity. This adaptability makes it an invaluable tool in medicinal chemistry.

The synthesis of Tert-butyl (3R)-3-bromopiperidine-1-carboxylate typically involves multi-step organic transformations starting from readily available precursors. The key steps often include halogenation of piperidine derivatives followed by protection-deprotection strategies to achieve the desired stereochemistry. Advances in synthetic methodologies have enabled more efficient and scalable production processes, reducing costs and improving yields. These advancements are crucial for ensuring that pharmaceutical companies can access sufficient quantities of this intermediate for preclinical and clinical studies.

In conclusion, Tert-butyl (3R)-3-bromopiperidine-1-carboxylate represents a significant advancement in pharmaceutical chemistry due to its structural versatility and biological relevance. Its applications in synthesizing novel drug candidates for neurological and metabolic disorders underscore its importance in modern drug discovery. As research continues to uncover new therapeutic targets and mechanisms, compounds like this will remain at the forefront of medicinal chemistry innovation.

• 1420816-48-3(Tert-Butyl 3-bromo-3-methylpiperidine-1-carboxylate)
• 180695-79-8(N-Boc-4-bromopiperidine)
• 849928-26-3(Tert-butyl 3-bromopiperidine-1-carboxylate)
• 1225276-07-2(tert-butyl 2-bromo-7-azaspiro[3.5]nonane-7-carboxylate)
• 569660-89-5((S)-tert-Butyl 3-bromopyrrolidine-1-carboxylate)
• 939793-16-5(Tert-butyl 3-bromopyrrolidine-1-carboxylate)
• 569660-97-5(tert-butyl (3R)-3-bromopyrrolidine-1-carboxylate)
• 889942-58-9(tert-Butyl 2-(bromomethyl)piperidine-1-carboxylate)
• 1420872-54-3(Tert-Butyl 2-(1-bromoethyl)piperidine-1-carboxylate)
• 1354017-20-1(tert-butyl (3S)-3-bromopiperidine-1-carboxylate)